keyword
https://read.qxmd.com/read/37247797/alleviating-the-virulence-of-pseudomonas-aeruginosa-and-staphylococcus-aureus-by-ascorbic-acid-nanoemulsion
#1
JOURNAL ARTICLE
Farag M Mosallam, Hisham A Abbas, Ghada H Shaker, Salwa E Gomaa
The high incidence of persistent multidrug resistant bacterial infections is a worldwide public health burden. Alternative strategies are required to deal with such issue including the use of drugs with anti-virulence activity. The application of nanotechnology to develop advanced Nano-materials that target quorum sensing regulated virulence factors is an attractive approach. Synthesis of ascorbic acid Nano-emulsion (ASC-NEs) and assessment of its activity in vitro against the virulence factors and its protective ability against pathogenesis as well as the effect against expression of quorum sensing genes of P...
May 27, 2023: Research in Microbiology
https://read.qxmd.com/read/35418077/microparticles-biogenesis-characteristics-and-intervention-therapy-for-cancers-in-preclinical-and-clinical-research
#2
REVIEW
Yan Hu, Yajie Sun, Chao Wan, Xiaomeng Dai, Shuhui Wu, Pui-Chi Lo, Jing Huang, Jonathan F Lovell, Honglin Jin, Kunyu Yang
Extracellular vesicles (EVs), spherical biological vesicles, mainly contain nucleic acids, proteins, lipids and metabolites for biological information transfer between cells. Microparticles (MPs), a subtype of EVs, directly emerge from plasma membranes, and have gained interest in recent years. Specific cell stimulation conditions, such as ultraviolet and X-rays irradiation, can induce the release of MPs, which are endowed with unique antitumor functionalities, either for therapeutic vaccines or as direct antitumor agents...
April 13, 2022: Journal of Nanobiotechnology
https://read.qxmd.com/read/33712991/hydroxycamptothecin-hcpt-loaded-peglated-lipid-polymer-hybrid-nanoparticles-for-effective-delivery-of-hcpt-qbd-based-development-and-evaluation
#3
JOURNAL ARTICLE
Ziwei Ma, Jingjing Liu, Xiaowen Li, Ying Xu, Dongchun Liu, Haibing He, Yanjiao Wang, Xing Tang
Lipid-polymer hybrid nanoparticles (LPNs) are promising drug delivery systems in various of disease treatment areas, particularly for cancer treatments. Here, a water-insoluble antitumor agent, hydroxycamptothecin (HCPT), was successfully incorporated into LPNs formed from polylactic-co-glycolic acid (PLGA), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-(methoxy(polyethylene glycol)-2000) (DSPE-PEG2000 ), and lecithin, by a modified single emulsification-solvent evaporation method. Quality-by-design (QbD) strategy composed of Plackett-Burman and Box-Behnken designs were applied for optimizing HCPT-LPNs with desired properties...
March 12, 2021: Drug Delivery and Translational Research
https://read.qxmd.com/read/32538291/involvement-of-cyp2d6-and-cyp2b6-on-tramadol-pharmacokinetics
#4
JOURNAL ARTICLE
Miriam Saiz-Rodríguez, Dolores Ochoa, Manuel Román, Pablo Zubiaur, Dora Koller, Gina Mejía, Francisco Abad-Santos
This study included 24 healthy volunteers who received a single 37.5 mg oral dose of tramadol. We analyzed 18 polymorphisms within CYP2D6 , CYP2B6 , CYP3A , COMT, ABCB1 , SLC22A1 and OPRM1 genes by quantitative PCR, to study whether these polymorphisms affect its pharmacokinetics, pharmacodynamics and safety. CYP2D6 intermediate metabolizers (n = 6) showed higher tramadol plasma concentrations and lower clearance compared with normal and ultrarapid metabolizers. CYP2B6 G516T T/T (n = 2) genotype was also associated to higher tramadol plasma levels...
June 15, 2020: Pharmacogenomics
https://read.qxmd.com/read/31849261/evaluation-of-optiflow%C3%A2-ms-ms-for-bioanalysis-of-pharmaceutical-drugs-and-metabolites
#5
JOURNAL ARTICLE
Jason Barricklow, Joseph Tweed, Christopher L Holliman, Ragu Ramanathan
Aim: Microflow tandem mass spectrometry-based methods have been proposed as options to improve sensitivity and selectivity while improving sample utility and solvent consumption. Here, we evaluate a newly introduced microflow source, OptiFlow™, for quantitative performance. Results/methodology: We performed a comparison of the OptiFlow and IonDrive™ sources, respectively, on the same triple quadrupole mass spectrometer. The comparison used a neat cocktail of commercially available drugs and extracted plasma samples monitoring midazolam and alprazolam metabolites...
January 2020: Bioanalysis
https://read.qxmd.com/read/31542274/use-of-a-glass-membrane-pumping-emulsification-device-improves-systemic-and-tumor-pharmacokinetics-in-rabbit-vx2-liver-tumor-in-transarterial-chemoembolization
#6
JOURNAL ARTICLE
Tetsuya Masada, Toshihiro Tanaka, Hideyuki Nishiofuku, Yasushi Fukuoka, Ryosuke Taiji, Takeshi Sato, Shota Tatsumoto, Kiyoyuki Minamiguchi, Nagaaki Marugami, Kimihiko Kichikawa
PURPOSE: To evaluate the phamacokinetics of epirubicin in conventional transarterial chemoembolization using a developed pumping emulsification device with a microporous glass membrane in VX2 rabbits. MATERIALS AND METHODS: Epirubicin solution (10 mg/mL) was mixed with ethiodized oil (1:2 ratio) using the device or 3-way stopcock. Forty-eight rabbits with VX2 liver tumor implanted 2 weeks prior to transarterial chemoembolization were divided into 2 groups: a device group (n = 24) and a 3-way-stopcock group (n = 24)...
September 18, 2019: Journal of Vascular and Interventional Radiology: JVIR
https://read.qxmd.com/read/29683659/the-identification-of-potent-selective-and-orally-available-inhibitors-of-ataxia-telangiectasia-mutated-atm-kinase-the-discovery-of-azd0156-8-6-3-dimethylamino-propoxy-pyridin-3-yl-3-methyl-1-tetrahydro-2-h-pyran-4-yl-1-3-dihydro-2-h-imidazo-4-5-c-quinolin
#7
JOURNAL ARTICLE
Kurt G Pike, Bernard Barlaam, Elaine Cadogan, Andrew Campbell, Yingxue Chen, Nicola Colclough, Nichola L Davies, Camila de-Almeida, Sebastien L Degorce, Myriam Didelot, Allan Dishington, Richard Ducray, Stephen T Durant, Lorraine A Hassall, Jane Holmes, Gareth D Hughes, Philip A MacFaul, Keith R Mulholland, Thomas M McGuire, Gilles Ouvry, Martin Pass, Graeme Robb, Natalie Stratton, Zhenhua Wang, Joanne Wilson, Baochang Zhai, Kang Zhao, Nidal Al-Huniti
ATM inhibitors, such as 7, have demonstrated the antitumor potential of ATM inhibition when combined with DNA double-strand break-inducing agents in mouse xenograft models. However, the properties of 7 result in a relatively high predicted clinically efficacious dose. In an attempt to minimize attrition during clinical development, we sought to identify ATM inhibitors with a low predicted clinical dose (<50 mg) and focused on strategies to increase both ATM potency and predicted human pharmacokinetic half-life (predominantly through the increase of volume of distribution)...
May 10, 2018: Journal of Medicinal Chemistry
https://read.qxmd.com/read/29493160/-effect-investigation-of-coumarin-constituents-in-angelica-dahurica-on-pharmacokinetics-of-docetaxel-by-lc-ms
#8
JOURNAL ARTICLE
Yong-Mei Guan, Wei-Feng Zhu, Xue-Jing Guan, Zheng-Gen Liao, Guo-Wei Zhao, Wei Dong, Xin-Li Liang
The study was aimed to establish a liquid chromatography-tandem mass spectrometric method for the determination of the docetaxel concentration in rat plasma, and study the effect of coumarin constituents (imperatorin, isoimperatorin and oxypeucedanin) in Angelica dahurica on pharmacokinetics of docetaxel.Plasma was precipitated with acetonitrile and determined by LC-MS method with Paclitaxel as an internal standard. The specificity, linearity, range, accuracy, precision and stability of the method were suitable for the determination of docetaxel in plasma...
December 2017: Zhongguo Zhong Yao za Zhi, Zhongguo Zhongyao Zazhi, China Journal of Chinese Materia Medica
https://read.qxmd.com/read/29217526/first-in-human-phase-i-study-of-single-agent-vanucizumab-a-first-in-class-bispecific-anti-angiopoietin-2-anti-vegf-a-antibody-in-adult-patients-with-advanced-solid-tumors
#9
JOURNAL ARTICLE
Manuel Hidalgo, Maria Martinez-Garcia, Christophe Le Tourneau, Christophe Massard, Elena Garralda, Valentina Boni, Alvaro Taus, Joan Albanell, Marie-Paule Sablin, Marie Alt, Ratislav Bahleda, Andrea Varga, Christophe Boetsch, Izolda Franjkovic, Florian Heil, Angelika Lahr, Katharina Lechner, Anthony Morel, Tapan Nayak, Simona Rossomanno, Kevin Smart, Kay Stubenrauch, Oliver Krieter
Purpose: Vanucizumab is an investigational antiangiogenic, first-in-class, bispecific mAb targeting VEGF-A and angiopoietin-2 (Ang-2). This first-in-human study evaluated the safety, pharmacokinetics, pharmacodynamics, and antitumor activity of vanucizumab in adults with advanced solid tumors refractory to standard therapies. Experimental Design: Patients received escalating biweekly (3-30 mg/kg) or weekly (10-30 mg/kg) intravenous doses guided by a Bayesian logistic regression model with overdose control. Results: Forty-two patients were treated...
April 1, 2018: Clinical Cancer Research
https://read.qxmd.com/read/28612545/-pharmacokinetics-of-curcumin-ethosomes-in-rats-in-vitro
#10
JOURNAL ARTICLE
Jing Zhao, Yuan Li, Ming-Xin Shi, Xue Wang, Jing-Qing Zhang
OBJECTIVES: To study the oral phamacokinetics of curcumin ethosomes in rats. METHODS: Pharmacokinetics parameters were detected by DAS 2.1.1 software analysis through data of blood concentrations harvested from HPLC after oral administration of curcumin ethosomes in rats. RESULTS: Analyzed by non-compartmental method, the area under concentration-time curve from 0 to last time [AUC(0-72h)] of curcumin ethosomes was 1.6 times larger than that of free curcumin, the peak concentration (C max) of curcumin ethosomes was 1...
March 2017: Sichuan da Xue Xue Bao. Yi Xue Ban, Journal of Sichuan University. Medical Science Edition
https://read.qxmd.com/read/28346018/antiretroviral-treatment-in-hiv-infected-children-who-require-a-rifamycin-containing-regimen-for-tuberculosis
#11
REVIEW
Helena Rabie, Eric H Decloedt, Anthony J Garcia-Prats, Mark F Cotton, Lisa Frigati, Marc Lallemant, Anneke Hesseling, H Simon Schaaf
In high prevalence settings, tuberculosis and HIV dual infection and co-treatment is frequent. Rifamycins, especially rifampicin, in combination with isoniazid, ethambutol and pyrazinamide are key components of short-course antituberculosis therapy. Areas covered: We reviewed available data, for which articles were identified by a Pubmed search, on rifamycin-antiretroviral interactions in HIV-infected children. Rifamycins have potent inducing effects on phase I and II drug metabolising enzymes and transporters...
April 2017: Expert Opinion on Pharmacotherapy
https://read.qxmd.com/read/27893751/25-hydroxy-and-1%C3%AE-25-dihydroxycholecalciferol-have-greater-potencies-than-25-hydroxy-and-1%C3%AE-25-dihydroxyergocalciferol-in-modulating-cultured-human-and-mouse-osteoblast-activities
#12
COMPARATIVE STUDY
Allahdad Zarei, Philippa A Hulley, Afsie Sabokbar, M Kassim Javaid, Alireza Morovat
Despite differences in the phamacokinetics of 25-hydroxycholecalciferol (25(OH)D3) and 25-hydroxyergocalciferol (25(OH)D2) in man, the effects of these and their 1α-hydroxylated forms (1,25(OH)2D3 and 1,25(OH)2D2) on cellular activity of vitamin D-responsive cells have hardly been compared. We studied differences in the effects of these metabolites on cell number, gene transcription, protein expression and mineralisation of cultured human bone marrow-derived stromal cells (hBMSC) and rapidly mineralising mouse 2T3 osteoblasts...
2016: PloS One
https://read.qxmd.com/read/26948677/aluminum-adjuvants-of-vaccines-injected-into-the-muscle-normal-fate-pathology-and-associated-disease
#13
REVIEW
R K Gherardi, J Aouizerate, J Cadusseau, S Yara, F J Authier
Aluminum oxyhydroxide (Alhydrogel(®)) is a nano-crystalline compound forming aggregates that has been introduced in vaccine for its immunologic adjuvant effect in 1926. It is the most commonly used adjuvant in human and veterinary vaccines but mechanisms by which it stimulates immune responses remain ill-defined. Although generally well tolerated on the short term, it has been suspected to occasionally cause delayed neurologic problems in susceptible individuals. In particular, the long-term persistence of aluminic granuloma also termed macrophagic myofasciitis is associated with chronic arthromyalgias and fatigue and cognitive dysfunction...
June 2016: Morphologie: Bulletin de L'Association des Anatomistes
https://read.qxmd.com/read/25416501/animal-models-for-exploring-the-pharmacokinetics-of-breast-cancer-therapies
#14
REVIEW
Omar M Rashid, Kazuaki Takabe
INTRODUCTION: Despite massive expenditures in research and development to cure breast cancer, few agents that pass preclinical trials demonstrate efficacy in humans. Although this endeavor relies on murine models to screen for efficacy before progressing to clinical trials, historically there has been little focus on the validation of these models, even in the era of targeted therapy where understanding the genetic signatures of tumors under study is critical. AREAS COVERED: This review includes the transgenic, xenograft, and syngeneic murine breast cancer models, the ectopic, orthotopic and intravenous methods of cell implantation, and the ethics of animal experimentation...
February 2015: Expert Opinion on Drug Metabolism & Toxicology
https://read.qxmd.com/read/25048669/mechanisms-in-photodynamic-therapy-part-three-photosensitizer-pharmacokinetics-biodistribution-tumor-localization-and-modes-of-tumor-destruction
#15
JOURNAL ARTICLE
Ana P Castano, Tatiana N Demidova, Michael R Hamblin
Photodynamic therapy (PDT) has been known for over a hundred years, but is only now becoming widely used. Originally developed as cancer therapy, some of its most successful applications are for non-malignant disease. The majority of mechanistic research into PDT, however, is still directed towards anti-cancer applications. In the final part of series of three reviews, we will cover the possible reasons for the well-known tumor localizing properties of photosensitizers (PS). When PS are injected into the bloodstream they bind to various serum proteins and this can affect their phamacokinetics and biodistribution...
June 2005: Photodiagnosis and Photodynamic Therapy
https://read.qxmd.com/read/24776763/study-on-biopharmaceutics-classification-and-oral-bioavailability-of-a-novel-multikinase-inhibitor-nce-for-cancer-therapy
#16
JOURNAL ARTICLE
Yang Yang, Chun-Mei Fan, Xuan He, Ke Ren, Jin-Kun Zhang, Ying-Ju He, Luo-Ting Yu, Ying-Lan Zhao, Chang-Yang Gong, Yu Zheng, Xiang-Rong Song, Jun Zeng
Specific biopharmaceutics classification investigation and study on phamacokinetic profile of a novel drug candidate (2-methylcarbamoyl-4-{4-[3- (trifluoromethyl) benzamido] phenoxy} pyridinium 4-methylbenzenesulfonate monohydrate, NCE) were carried out. Equilibrium solubility and intrinsic dissolution rate (IDR) of NCE were estimated in different phosphate buffers. Effective intestinal permeability (P(eff)) of NCE was determined using single-pass intestinal perfusion technique in rat duodenum, jejunum and ileum at three concentrations...
2014: International Journal of Molecular Sciences
https://read.qxmd.com/read/24154682/phamacokinetics-of-rivaroxaban-in%C3%A2-adolescents
#17
JOURNAL ARTICLE
J Beyer-Westendorf, S Gehrisch
BACKGROUND: The direct factor Xa inhibitor rivaroxaban is approved for venous thromboembolism (VTE) treatment in adults. However, in all phase-III trials children or adolescents have not been included. For under-aged VTE patients, current standard treatment consists of low molecular weight heparin or Vitamin K antagonists. Rivaroxaban could be an attractive alternative, however, no data on the pharmacokinetics (PK) of rivaroxaban in adolescents are currently available. PATIENT, METHODS: We report PK data for rivaroxaban derived from a girl (age:15 years), who presented three month after acute deep vein thrombosis, already receiving rivaroxaban therapy...
2014: Hämostaseologie
https://read.qxmd.com/read/23498916/vbp15-preclinical-characterization-of-a-novel-anti-inflammatory-delta-9-11-steroid
#18
JOURNAL ARTICLE
Erica K M Reeves, Eric P Hoffman, Kanneboyina Nagaraju, Jesse M Damsker, John M McCall
Δ9,11 modifications of glucocorticoids (21-aminosteroids) have been developed as drugs for protection against cell damage (lipid peroxidation; lazaroids) and inhibition of neovascularization (anecortave). Part of the rationale for developing these compounds has been the loss of glucocorticoid receptor binding due to the Δ9,11 modification, thus avoiding many immunosuppressive activities and deleterious side effect profiles associated with binding to glucocorticoid and mineralocorticoid receptors. We recently demonstrated that anecortave acetate and its 21-hydroxy analog (VBP1) do, in fact, show glucocorticoid and mineralocorticoid receptor binding activities, with potent translocation of the glucocorticoid receptor to the cell nucleus...
April 15, 2013: Bioorganic & Medicinal Chemistry
https://read.qxmd.com/read/23461441/-pharmaceutical-care-in-renal-insufficiency-inpatients
#19
JOURNAL ARTICLE
C Devesa García, C Matoses Chirivella, L Peral Ballester, G Sanz Tamargo, A C Murcia López, A Navarro Ruiz
BACKGROUND AND OBJECTIVE: To asses the outcomes of posological adjust program in renal impairment inpatients, describe the drugs more usually involved, and determine the degree of acceptance of the pharmaceutical intervention made. MATERIAL AND METHOD: A fifteen months-prospective study, in renal insufficiency inpatients (serum creatinine > 1,4 mg/dL) treated with drugs that needs posological adjustment. The primary outcome was the ratio of adequate dosage of the treatment, according with the glomerular filtration rate...
November 2012: Farmacia Hospitalaria
https://read.qxmd.com/read/23389953/carbohydrate-mediated-polyethylene-glycol-conjugation-of-tsh-improves-its-pharmacological-properties
#20
JOURNAL ARTICLE
Anna Park, Denise M Honey, Lihui Hou, Julie J Bird, Christine Zarazinski, Michelle Searles, Christian Braithwaite, Jonathan S Kingsbury, Josephine Kyazike, Kerry Culm-Merdek, Ben Greene, James E Stefano, Huawei Qiu, John M McPherson, Clark Q Pan
Thyrogen (thyrotropin alfa for injection), recombinant human TSH (rhTSH), has been successfully used to enhance diagnostic radioiodine scanning and thyroglobulin testing in the follow-up of patients with thyroid cancer and as an adjunctive treatment for radioiodine thyroid remnant ablation. However, the short half-life of rhTSH in the circulation requires a multidose regimen. We developed novel sialic acid-mediated and galactose-mediated conjugation chemistries for targeting polyethylene glycol (PEG) to the three N-linked glycosylation sites on the protein, to prolong plasma half-life by eliminating kidney filtration and potential carbohydrate-mediated clearance...
March 2013: Endocrinology
keyword
keyword
91342
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.